I’d say that’s getting a bit far ahead of things yet. The business vs what the market knows about them are still a long way apart.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025